REduCing Immunogenicity to PegloticasE (RECIPE) Study

Trial Profile

REduCing Immunogenicity to PegloticasE (RECIPE) Study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jun 2018

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Pegloticase
  • Indications Gout
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Acronyms RECIPE
  • Most Recent Events

    • 30 May 2018 Status changed from not yet recruiting to recruiting.
    • 26 Apr 2018 Planned initiation date changed from 15 Apr 2018 to 15 May 2018.
    • 09 Mar 2018 Planned initiation date changed from 1 Mar 2018 to 15 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top